Maimonides Medical Center
maimonidesmed.orgTotal trials
53
Active
5
Phase 3
3
Total enrollment
3,397
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Vaginal Cream with Applicator | — | — | — | — | — | 1 | |
| Cabergoline | — | — | — | — | — | 1 |
Next readouts
- 2026-08-31
- 2028-02
Top conditions
- Postoperative Pain3
- Prostate Cancer3
- Radiation Exposure2
- Polycystic Ovary Syndrome2
- Vitamin D Deficiency2
- Frail Elderly2
- Prader-Willi Syndrome2
- Aggression2
Frequently asked questions about Maimonides Medical Center
- How many clinical trials does Maimonides Medical Center have on ClinicalTrials.gov?
- Maimonides Medical Center is listed as the lead sponsor on 53 clinical trials in ClinicalTrials.gov, 5 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Maimonides Medical Center's trials are in Phase 3?
- 3 of Maimonides Medical Center's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Maimonides Medical Center focus on?
- Maimonides Medical Center's most-studied conditions on ClinicalTrials.gov are Postoperative Pain, Prostate Cancer, Radiation Exposure, Polycystic Ovary Syndrome, Vitamin D Deficiency.
- When are Maimonides Medical Center's next clinical trial readouts?
- Maimonides Medical Center has 2 upcoming primary-completion readouts tracked here; the soonest is “Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo”, expected around 2026-08-31.